| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-05 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.12 | 3e-05 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |